Collegium Pharmaceutical Ownership | Who Owns Collegium Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

Collegium Pharmaceutical Ownership Summary


Collegium Pharmaceutical is owned by 123.36% institutional investors, 1.15% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.96% of COLL shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.09% of its assets in Collegium Pharmaceutical shares.

COLL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCollegium Pharmaceutical123.36%1.15%-24.51%
SectorHealthcare Stocks 50.53%12.40%37.07%
IndustrySpecialty & Generic Drug Manufacturers Stocks35.91%15.07%49.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.44M16.96%$196.97M
Vanguard group2.26M7.15%$104.46M
Invesco1.88M5.87%$68.15M
Janus henderson group1.83M5.76%$60.36M
Fuller & thaler asset management1.63M5.09%$59.11M
Principal financial group1.63M5.09%$59.09M
State street1.53M4.76%$55.35M
Massachusetts financial services co /ma/1.41M4.38%$50.88M
Vanguard capital management1.38M4.30%$50.00M
Renaissance1.37M4.26%$49.47M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ballast asset management, lp112.11K1.62%$4.06M
Goldentree asset management lp744.89K1.56%$26.92M
Third avenue management182.65K1.06%$6.61M
Eventide asset management1.36M0.66%$49.27M
Jackson creek investment advisors42.66K0.50%$1.51M
Watershed asset management14.97K0.48%$541.91K
Summerhaven investment management22.76K0.44%$823.77K
Rubric capital management lp1.28M0.42%$46.32M
Uniplan investment counsel116.36K0.40%$4.21M
Values first advisors35.000.31%$652.06K

Top Buyers

HolderShares% AssetsChange
Goldentree asset management lp744.89K1.56%744.89K
Sixth street partners management company486.60K0.00%486.60K
Janus henderson group1.83M0.03%377.07K
Millennium management736.92K0.01%376.10K
Principal financial group1.63M0.03%337.33K

Top Sellers

HolderShares% AssetsChange
Marshall wace, llp253.35K0.01%-495.46K
Two sigma investments, lp106.70K0.00%-483.41K
Emerald advisers1.05K0.00%-401.70K
Emerald mutual fund advisers trust---306.07K
J. goldman & co lp---243.45K

New Positions

HolderShares% AssetsChangeValue
Goldentree asset management lp744.89K1.56%744.89K$26.92M
Sixth street partners management company486.60K0.00%486.60K$17.61M
First trust advisors lp174.29K0.00%174.29K$6.31M
Point72 asset management114.01K0.00%114.01K$4.13M
Norges bank112.50K0.00%112.50K$5.21M

Sold Out

HolderChange
Stephens consulting-1.00
Larson financial group-2.00
Lindbrook capital-2.00
Hughes financial services-3.00
Mendota financial group-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20262794.49%39,582,6554.22%1230.86%1627.28%8510.39%
Mar 31, 2026158-43.17%16,783,792-54.78%520.38%85-37.04%45-58.72%
Dec 31, 2025189-22.54%28,523,231-22.90%900.67%83-36.15%77-10.47%
Sep 30, 20252327.91%36,812,0797.39%1151.00%12314.95%846.33%
Jun 30, 2025219-10.61%35,601,778-3.13%1110.84%106-2.75%83-15.31%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.98M6.09%1.36K
FullerThaler Behavioral Small-Cap Equity1.56M4.81%130.70K
FullerThaler Beh Small-Cap Equity SMA1.56M4.81%130.70K
FullerThaler Behavioral Sm-Cp Eq R61.43M4.41%-
Eventide Gilead N1.34M4.15%-
Janus Henderson Hrzn Glb SC E2 USD1.23M3.78%97.40K
Vanguard US Total Market Shares ETF993.93K3.09%-
Vanguard Morn Total Stk Mkt Idx Investor977.96K3.02%29.30K
Vanguard Total Stock Mkt Idx Inv977.96K3.02%29.30K
Vanguard MStar Total Stk Mkt Idx Invest977.96K3.00%-

Recent Insider Transactions


DateNameRoleActivityValue
May 18, 2026Freund John Gordon-Sell$681.00
May 15, 2026Freund John Gordon-Sell$142.55K
May 13, 2026Lurker Nancy-Sell$161.86K
May 11, 2026BOHLIN GAREN G-Sell$323.49K
Mar 18, 2026Dieter David EVP & General CounselSell$488.10K

Insider Transactions Trends


DateBuySell
2026 Q2-4
2026 Q1-3
2025 Q4-6
2025 Q3-6
2025 Q2-1

COLL Ownership FAQ


Who Owns Collegium Pharmaceutical?

Collegium Pharmaceutical shareholders are primarily institutional investors at 123.36%, followed by 1.15% insiders and -24.51% retail investors. The average institutional ownership in Collegium Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 35.91%, which Collegium Pharmaceutical exceeds.

Who owns the most shares of Collegium Pharmaceutical?

Collegium Pharmaceutical’s largest shareholders are Blackrock funding, inc. /de (5.44M shares, 16.96%), Vanguard group (2.26M shares, 7.15%), and Invesco (1.88M shares, 5.87%). Together, they hold 29.97% of Collegium Pharmaceutical’s total shares outstanding.

Does Blackrock own Collegium Pharmaceutical?

BlackRock is not among the top 10 institutional shareholders of Collegium Pharmaceutical.

Who is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Ballast asset management, lp is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 1.62% of its assets in 112.11K Collegium Pharmaceutical shares, valued at 4.06M$.

Who is the top mutual fund holder of Collegium Pharmaceutical shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Collegium Pharmaceutical shares, with 6.09% of its total shares outstanding invested in 1.98M Collegium Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools